Agricultural biotech company MustGrow Biologics today announced the closing of a non-brokered private placement. According to the update, the offering consists of 1,712,533 of MustGrow common shares, each at a $0.70 price per common share, for gross proceeds of $1,198,773. The company intends to use the net proceeds to accelerate research and development of its bio-pesticide and bio-fertilizer formulations, as well as for working capital and general corporate purposes. MustGrow plans to direct research and development proceeds toward its patented mustard-derived signature products and its prospective suite of in-licensed natural biologics.
To view the full press release, visit http://ibn.fm/q2F1N
About MustGrow Biologics Corp.
MustGrow Biologics is an agricultural biotech company that develops and commercializes patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high-quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides. For more information, visit the company’s website at www.MustGrow.ca.
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.